The University of Chicago Header Logo

Connection

Mark Talamonti to Aged

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Aged.
Mark Talamonti
Connection Strength
1.542
Aged
  1. Endovascular management of portal vein obstruction in hepatobiliary cancer patients. J Surg Oncol. 2022 Mar; 125(3):392-398.
    View in: PubMed
    Score: 0.058
  2. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature. Expert Opin Biol Ther. 2020 06; 20(6):665-672.
    View in: PubMed
    Score: 0.052
  3. Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience. Expert Opin Biol Ther. 2020 01; 20(1):95-104.
    View in: PubMed
    Score: 0.051
  4. Postoperative venous thromboembolism and mortality in patients with pancreatic surgery. J Surg Oncol. 2019 Sep; 120(3):494-500.
    View in: PubMed
    Score: 0.049
  5. Pancreatic cancer thromboembolic outcomes: rate of thrombosis after adenocarcinoma and non-adenocarcinoma pancreatic cancer surgery. Int Angiol. 2019 Jun; 38(3):194-200.
    View in: PubMed
    Score: 0.049
  6. Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study. J Eur Acad Dermatol Venereol. 2018 Oct; 32(10):1737-1744.
    View in: PubMed
    Score: 0.046
  7. Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients. Br J Dermatol. 2017 Aug; 177(2):489-496.
    View in: PubMed
    Score: 0.043
  8. Percutaneous transhepatic placement of a stent-graft to treat a delayed mesoportal hemorrhage after pancreaticoduodenectomy. World J Surg Oncol. 2014 Oct 15; 12:315.
    View in: PubMed
    Score: 0.036
  9. Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: defining quality for pancreaticoduodenectomy. J Surg Oncol. 2014 Sep; 110(4):400-6.
    View in: PubMed
    Score: 0.035
  10. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2013 Oct; 154(4):785-91; discussion 791-3.
    View in: PubMed
    Score: 0.033
  11. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. Br J Dermatol. 2013 Aug; 169(2):458-63.
    View in: PubMed
    Score: 0.033
  12. Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer. Int J Radiat Oncol Biol Phys. 2011 Jun 01; 80(2):476-82.
    View in: PubMed
    Score: 0.028
  13. Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension. Dermatology. 2011; 222(3):250-5.
    View in: PubMed
    Score: 0.028
  14. Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy. Am J Surg. 2011 Mar; 201(3):295-9; discussion 299-300.
    View in: PubMed
    Score: 0.028
  15. A prospective single institution comparison of peri-operative outcomes for laparoscopic and open distal pancreatectomy. Surgery. 2009 Oct; 146(4):635-43; discussion 643-5.
    View in: PubMed
    Score: 0.025
  16. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009 Jan; 249(1):63-71.
    View in: PubMed
    Score: 0.024
  17. Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals. Am J Surg. 2007 Nov; 194(5):588-93.
    View in: PubMed
    Score: 0.022
  18. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007 Oct; 142(4):529-34; discussion 534-7.
    View in: PubMed
    Score: 0.022
  19. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Cancer. 2007 Sep 15; 110(6):1227-34.
    View in: PubMed
    Score: 0.022
  20. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007 Oct; 205(4):558-63.
    View in: PubMed
    Score: 0.022
  21. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007 Aug; 246(2):173-80.
    View in: PubMed
    Score: 0.022
  22. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg. 2007 Mar; 193(3):389-93; discussion 393-4.
    View in: PubMed
    Score: 0.021
  23. Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experience. Am J Surg. 2006 Mar; 191(3):437-41.
    View in: PubMed
    Score: 0.020
  24. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol. 2006 Feb; 13(2):150-8.
    View in: PubMed
    Score: 0.019
  25. Preoperative evaluation of pancreatic cystic lesions: cost-benefit analysis and proposed management algorithm. Surgery. 2005 Oct; 138(4):672-9; discussion 679-80.
    View in: PubMed
    Score: 0.019
  26. Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations. Sci Rep. 2024 07 08; 14(1):15744.
    View in: PubMed
    Score: 0.018
  27. The minimally invasive approach confers improved outcomes in frail cancer patients undergoing hepatectomy: an American College of Surgeons National Surgical Quality Improvement Program analysis. J Gastrointest Surg. 2024 Jul; 28(7):1017-1026.
    View in: PubMed
    Score: 0.017
  28. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. 2004; 22(2):225-33.
    View in: PubMed
    Score: 0.017
  29. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003 Oct; 134(4):720-7; discussion 727-9.
    View in: PubMed
    Score: 0.017
  30. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial. JAMA. 2023 05 09; 329(18):1579-1588.
    View in: PubMed
    Score: 0.016
  31. Pathologic quiz case: a cystic pancreatic mass discovered in a patient with ileocecal carcinoid. Arch Pathol Lab Med. 2002 Feb; 126(2):229-30.
    View in: PubMed
    Score: 0.015
  32. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study. J Eur Acad Dermatol Venereol. 2021 Apr; 35(4):958-964.
    View in: PubMed
    Score: 0.014
  33. Screening for colorectal cancer: developing a preventive healthcare program utilizing nurse endoscopists. Gastroenterol Nurs. 2001 Jan-Feb; 24(1):12-9.
    View in: PubMed
    Score: 0.014
  34. Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank. Int J Cancer. 2021 04 01; 148(7):1658-1664.
    View in: PubMed
    Score: 0.014
  35. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol. 2000 Oct 01; 18(19):3384-9.
    View in: PubMed
    Score: 0.014
  36. Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching. J Surg Oncol. 2020 Aug; 122(2):183-194.
    View in: PubMed
    Score: 0.013
  37. The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. PLoS One. 2018; 13(8):e0202272.
    View in: PubMed
    Score: 0.012
  38. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793.
    View in: PubMed
    Score: 0.011
  39. Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score). Ann Surg. 2018 04; 267(4):716-720.
    View in: PubMed
    Score: 0.011
  40. Minimally invasive pancreatoduodenectomy: is the incidence of clinically relevant postoperative pancreatic fistula comparable to that after open pancreatoduodenectomy? Surgery. 2018 03; 163(3):587-593.
    View in: PubMed
    Score: 0.011
  41. Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function. Surgery. 2018 03; 163(3):582-586.
    View in: PubMed
    Score: 0.011
  42. Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? Surgery. 2018 05; 163(5):1047-1052.
    View in: PubMed
    Score: 0.011
  43. The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy. HPB (Oxford). 2018 02; 20(2):140-146.
    View in: PubMed
    Score: 0.011
  44. Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
    View in: PubMed
    Score: 0.011
  45. Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function. Surgery. 2017 11; 162(5):1032-1039.
    View in: PubMed
    Score: 0.011
  46. Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy. J Gastrointest Surg. 2017 Oct; 21(10):1620-1625.
    View in: PubMed
    Score: 0.011
  47. Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience. Ann Surg Oncol. 2017 Sep; 24(9):2770-2776.
    View in: PubMed
    Score: 0.011
  48. Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy. J Am Coll Surg. 2017 May; 224(5):816-825.
    View in: PubMed
    Score: 0.011
  49. Rectus abdominis atrophy after ventral abdominal incisions: midline versus chevron. Hernia. 2017 08; 21(4):619-622.
    View in: PubMed
    Score: 0.011
  50. Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy. Am J Surg. 2017 Mar; 213(3):512-515.
    View in: PubMed
    Score: 0.010
  51. Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis. J Dermatolog Treat. 2017 Jun; 28(4):299-303.
    View in: PubMed
    Score: 0.010
  52. A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy. Ann Surg. 2016 Oct; 264(4):640-9.
    View in: PubMed
    Score: 0.010
  53. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma. Surgery. 2016 12; 160(6):1466-1476.
    View in: PubMed
    Score: 0.010
  54. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg. 2016 08 17; 151(8):e161137.
    View in: PubMed
    Score: 0.010
  55. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head. Surgery. 2016 09; 160(3):714-24.
    View in: PubMed
    Score: 0.010
  56. A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. J Gastrointest Surg. 2016 Feb; 20(2):284-92.
    View in: PubMed
    Score: 0.010
  57. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy. Ann Surg Oncol. 2016 06; 23(6):1956-62.
    View in: PubMed
    Score: 0.010
  58. Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base. J Am Coll Surg. 2015 Jul; 221(1):175-84.
    View in: PubMed
    Score: 0.009
  59. Educating surgeons may allow for reduced intraoperative costs for inguinal herniorrhaphy. J Am Coll Surg. 2015 Jun; 220(6):1107-12.
    View in: PubMed
    Score: 0.009
  60. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Surg Endosc. 2015 Dec; 29(12):3528-34.
    View in: PubMed
    Score: 0.009
  61. The laparoscopic approach to distal pancreatectomy for ductal adenocarcinoma results in shorter lengths of stay without compromising oncologic outcomes. Am J Surg. 2015 Mar; 209(3):557-63.
    View in: PubMed
    Score: 0.009
  62. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015 Jul; 22(7):2209-17.
    View in: PubMed
    Score: 0.009
  63. CA 19-9 nonproduction is associated with poor survival after resection of pancreatic adenocarcinoma. Am J Clin Oncol. 2014 Dec; 37(6):550-4.
    View in: PubMed
    Score: 0.009
  64. Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014 Dec; 156(6):1504-10; discussion 1510-1.
    View in: PubMed
    Score: 0.009
  65. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors. J Gastrointest Surg. 2015 Jan; 19(1):117-23; discussion 123.
    View in: PubMed
    Score: 0.009
  66. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Ann Surg. 2014 Aug; 260(2):372-7.
    View in: PubMed
    Score: 0.009
  67. Predicting regression of Barrett's esophagus: results from a retrospective cohort of 1342 patients. Surg Endosc. 2014 Oct; 28(10):2803-7.
    View in: PubMed
    Score: 0.009
  68. Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014 May; 21(5):1520-9.
    View in: PubMed
    Score: 0.009
  69. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. Surg Gynecol Obstet. 1993 Nov; 177(5):481-7.
    View in: PubMed
    Score: 0.008
  70. Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study. J Gastrointest Surg. 2013 Jan; 17(1):94-100; discussion p. 100-1.
    View in: PubMed
    Score: 0.008
  71. Laparoscopic ischemic conditioning of the stomach prior to esophagectomy. Dis Esophagus. 2013 Jul; 26(5):479-86.
    View in: PubMed
    Score: 0.008
  72. Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study. Clin Dev Immunol. 2012; 2012:823854.
    View in: PubMed
    Score: 0.008
  73. Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292). Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e607-13.
    View in: PubMed
    Score: 0.007
  74. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):189-98.
    View in: PubMed
    Score: 0.007
  75. The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab. Dermatology. 2010; 221 Suppl 1:43-7.
    View in: PubMed
    Score: 0.007
  76. Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg. 1990 Aug; 125(8):972-6; discussion 976-7.
    View in: PubMed
    Score: 0.007
  77. Risk-based selective referral for cancer surgery: a potential strategy to improve perioperative outcomes. Ann Surg. 2010 Apr; 251(4):708-16.
    View in: PubMed
    Score: 0.007
  78. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer. 2010 Apr 01; 116(7):1674-80.
    View in: PubMed
    Score: 0.007
  79. Mucinous nonneoplastic cyst of the pancreas: apomucin phenotype distinguishes this entity from intraductal papillary mucinous neoplasm. Hum Pathol. 2010 Apr; 41(4):513-21.
    View in: PubMed
    Score: 0.006
  80. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst. 2009 Jun 16; 101(12):848-59.
    View in: PubMed
    Score: 0.006
  81. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer. 2009 May 01; 115(9):1849-58.
    View in: PubMed
    Score: 0.006
  82. Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers. Dermatology. 2009; 219(1):48-53.
    View in: PubMed
    Score: 0.006
  83. Methylation profile of circulating plasma DNA in patients with pancreatic cancer. J Surg Oncol. 2009 Feb 01; 99(2):119-22.
    View in: PubMed
    Score: 0.006
  84. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg. 2008 Dec; 12(12):2078-86.
    View in: PubMed
    Score: 0.006
  85. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst. 2008 Sep 17; 100(18):1310-7.
    View in: PubMed
    Score: 0.006
  86. Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg. 2008 Sep; 248(3):438-46.
    View in: PubMed
    Score: 0.006
  87. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg. 2008 Jul; 143(7):671-8; discussion 678.
    View in: PubMed
    Score: 0.006
  88. Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg. 2008 Oct; 207(4):510-9.
    View in: PubMed
    Score: 0.006
  89. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008 Oct 01; 26(28):4626-33.
    View in: PubMed
    Score: 0.006
  90. Sociodemographic and tumor characteristics associated with pancreatic cancer surgery in the United States. J Surg Oncol. 2008 Jun 01; 97(7):578-82.
    View in: PubMed
    Score: 0.006
  91. The oblique rectus abdominal myocutaneous flap for complex pelvic wound reconstruction. Dis Colon Rectum. 2008 Aug; 51(8):1237-41.
    View in: PubMed
    Score: 0.006
  92. Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg. 2008 Jul; 196(1):135-8.
    View in: PubMed
    Score: 0.006
  93. Squamous cell carcinoma of the anal canal: utilization and outcomes of recommended treatment in the United States. Ann Surg Oncol. 2008 Jul; 15(7):1948-58.
    View in: PubMed
    Score: 0.006
  94. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol. 2008 Jun; 15(6):1566-76.
    View in: PubMed
    Score: 0.006
  95. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg. 2008 Mar; 247(3):490-500.
    View in: PubMed
    Score: 0.006
  96. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008 Feb 20; 26(6):942-7.
    View in: PubMed
    Score: 0.006
  97. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum. 2008 Feb; 51(2):154-61.
    View in: PubMed
    Score: 0.006
  98. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery. 2007 Dec; 142(6):906-13; discussion 913.e1-2.
    View in: PubMed
    Score: 0.006
  99. Surgical considerations for the management and resection of esophageal gastrointestinal stromal tumors. Ann Thorac Surg. 2007 Nov; 84(5):1717-23.
    View in: PubMed
    Score: 0.006
  100. Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg. 2008 Feb; 206(2):247-54.
    View in: PubMed
    Score: 0.006
  101. Impact of adjuvant radiation on survival: a note of caution when using cancer registry data to evaluate adjuvant treatments. Ann Surg Oncol. 2007 Dec; 14(12):3321-7.
    View in: PubMed
    Score: 0.005
  102. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J Gastrointest Surg. 2007 Nov; 11(11):1460-7; discussion 1467-9.
    View in: PubMed
    Score: 0.005
  103. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007 Sep; 246(3):375-81; discussion 381-4.
    View in: PubMed
    Score: 0.005
  104. Long-term treatment of plaque psoriasis with efalizumab: an Italian experience. Br J Dermatol. 2007 Apr; 156 Suppl 2:17-23.
    View in: PubMed
    Score: 0.005
  105. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in carcinoid tumors. Mod Pathol. 2002 Dec; 15(12):1333-8.
    View in: PubMed
    Score: 0.004
  106. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 2001 Oct; 130(4):677-82; discussion 682-5.
    View in: PubMed
    Score: 0.004
  107. Molecular markers and prediction of response to chemoradiation in rectal cancer. Oncol Rep. 2001 May-Jun; 8(3):497-500.
    View in: PubMed
    Score: 0.004
  108. Primary gastrointestinal sarcomas: analysis of prognostic factors and results of surgical management. Surgery. 2000 Oct; 128(4):604-12.
    View in: PubMed
    Score: 0.003
  109. Results of gastric interposition for reconstruction of the pharyngoesophagus. Surgery. 1999 Oct; 126(4):666-71; discussion 671-2.
    View in: PubMed
    Score: 0.003
  110. Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol. 1997 Jan; 64(1):74-8.
    View in: PubMed
    Score: 0.003
  111. Cystic neoplasms of the pancreas. A clinicopathologic study, including DNA flow cytometry. Arch Surg. 1995 Oct; 130(10):1048-54.
    View in: PubMed
    Score: 0.002
  112. Expression of p68 in human colon cancer. Tumour Biol. 1995; 16(5):281-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.